(R)-8-(3-Aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-6-((4-methylquinazolin-2-yl)methoxy)-3,7-dihydro-2H-purin-2-one
| Product Name |
(R)-8-(3-Aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-6-((4-methylquinazolin-2-yl)methoxy)-3,7-dihydro-2H-purin-2-one
|
| Product Code |
DA-L057-ba
|
| Chemical name |
(R)-8-(3-Aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-6-((4-methylquinazolin-2-yl)methoxy)-3,7-dihydro-2H-purin-2-one
|
| Synonyms |
2H-Purin-2-one, 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-6-[(4-methyl-2-quinazolinyl)methoxy];
|
| Impurity |
NA
|
| CAS Number |
2514724-20-8
|
| Alternate CAS # |
NA
|
| Molecular form |
C25H28N8O2
|
| Appearance |
NA
|
| Melting Point |
NA
|
| Mol. Weight |
472.55
|
| Storage |
2-8°C Refrigerator
|
| Solubility |
NA
|
| Stability |
NA
|
| Category |
impurities,metabolites,pharmaceutical standards,intermediates,Fine Chemicals
|
| Boiling Point |
NA
|
| Applications |
(R)-8-(3-Aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-6-((4-methylquinazolin-2-yl)methoxy)-3,7-dihydro-2H-purin-2-one is the impurity of the drug Linagliptin . Linagliptin is a novel potent and selective dipeptidyl peptidase-4 inhibitor with potential use in the treatment of type 2 diabetes.
|
| Dangerous Goods Info |
NA
|
| References |
NA
|
| Extra Notes |
NA
|
| Documents (MSDS) |
No Data Available
|
| Keywords |
NA |
